Sanofi Finalizes Acquisition of Vicebio for $1.6 Billion, Aiming to Transform Biopharma Landscape Sanofi has officially acquired Vicebio for $1.6 billion, gaining innovative vaccine technology that targets respiratory viruses and promising clinical developments.

Sanofi Finalizes Acquisition of Vicebio for $1.6 Billion, Aiming to Transform Biopharma Landscape #London #United_Kingdom #Sanofi #Vicebio #Molecular_Clamp